Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9905 - 9912 of 11616 results
Did The Supreme Court Finally Explain Marathon And Stern? Executive Benefits’ Impact on Bankruptcy Court Jurisdiction
June 27, 2014| Advisory| Viewpoint
SCOTUS to Police on Cellphone Searches: "Get a warrant"
June 27, 2014| Blog| Viewpoint
Wyndham Gets Life Preserver in Data Breach Case
June 27, 2014| Blog| Viewpoint
Supreme Court Finally Decides Noel Canning and Says President Obama’s Recess Appointments to the NLRB are a No Go.
June 26, 2014| Blog| Viewpoint
Can A Relator Be Held Liable For Using Confidential Company Documents To Support A Qui Tam Case?
June 26, 2014| Blog| Viewpoint
Admirals Bank Partners with SunPower for an Innovative Solar Power Loan Funding Program
June 26, 2014| Blog| Viewpoint
D'oh! OCR Confirms that Medical Records Should Not be Left in the Driveway
June 26, 2014| Blog| Viewpoint
To our US Readers: Your Privacy & Security Matters Blog Public Service for Thursday, June 26
June 26, 2014| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.